BTMD
biote Corp.
Price Chart
Latest Quote
$2.26
-0.01 (-0.44%)
Current Price
| Previous Close | $2.27 |
| Open | $2.29 |
| Day High | $2.33 |
| Day Low | $2.19 |
| Volume | 160,925 |
Stock Information
| Shares Outstanding | 30.33M |
| Total Debt | $108.42M |
| Cash Equivalents | $5.32M |
| Revenue | $188.16M |
| Net Income | $15.60M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $80.35M |
| P/E Ratio | 5.26 |
| EPS (TTM) | $0.43 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $177.66M |
| Sales | $188.16M |
| Income | $15.60M |
| Book/sh | $-1.87 |
| Cash/sh | $0.18 |
| Employees | 223 |
Financial Ratios
| Quick Ratio | 0.45 |
| Current Ratio | 1.29 |
| EPS Growth TTM | -83.40% |
Returns & Margins
| ROA | 17.81% |
| Gross Margin | 70.12% |
| Operating Margin | 9.78% |
| Profit Margin | 8.29% |
Ownership
| Insider Ownership | 10.39% |
| Institutional Ownership | 66.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 3.96 |
| P/S | 0.43 |
| P/B | -1.21 |
Analyst Data
| Recommendation | none |
| Target Price | $2.99 |
Technical Indicators
| SMA20 | $2.19 |
| SMA50 | $2.13 |
| SMA200 | $2.38 |
| RSI | 60.83 |
| ATR | 0.1621 |
| Shares Float | 19.62M |
| Short Float | 6.42% |
| Short Ratio | 6.37 |
| Volatility | 1.66 |
| Rel Volume | 0.79 |
Performance History
| Week | -7.00% |
| Month | +14.43% |
| Quarter | +56.94% |
| 6 Months | -15.36% |
| YTD | -8.50% |
| Year | -42.49% |
| 3 Years | -59.71% |
| 5 Years | -76.94% |
| 10 Years | -77.51% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $2.26 | 160,925 |
| 2026-06-17 | $2.27 | 153,300 |
| 2026-06-16 | $2.19 | 198,800 |
| 2026-06-15 | $2.25 | 227,000 |
| 2026-06-12 | $2.46 | 223,400 |
| 2026-06-11 | $2.43 | 153,100 |
| 2026-06-10 | $2.27 | 133,100 |
| 2026-06-09 | $2.21 | 482,800 |
| 2026-06-08 | $2.34 | 107,500 |
| 2026-06-05 | $2.34 | 77,000 |
| 2026-06-04 | $2.36 | 251,600 |
| 2026-06-03 | $2.11 | 192,000 |
| 2026-06-02 | $2.15 | 217,600 |
| 2026-06-01 | $2.11 | 263,500 |
| 2026-05-29 | $2.00 | 119,400 |
| 2026-05-28 | $2.04 | 289,700 |
| 2026-05-27 | $2.00 | 220,500 |
| 2026-05-26 | $1.92 | 308,400 |
| 2026-05-22 | $1.99 | 166,900 |
| 2026-05-21 | $2.07 | 143,700 |
| 2026-05-20 | $2.10 | 163,800 |
| 2026-05-19 | $1.98 | 258,300 |
About biote Corp.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.
đ° Latest News
How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations
Simply Wall St. âĸ 2026-06-06T08:06:07Z
biote Corp. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T12:30:00Z
biote Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-06T23:35:21Z
biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates
Zacks âĸ 2026-05-06T22:30:19Z
How The biote (BTMD) Narrative Is Shifting As Targets Tighten And Guidance Holds
Simply Wall St. âĸ 2026-05-02T19:16:04Z
GE HealthCare Technologies (GEHC) Lags Q1 Earnings Estimates
Zacks âĸ 2026-04-29T11:45:04Z
How The Investment Story For Biote (BTMD) Is Shifting With Reset Expectations And 2026 Guidance
Simply Wall St. âĸ 2026-04-04T17:08:57Z
Biote Corp (BTMD) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges
GuruFocus.com âĸ 2026-03-12T03:00:31Zbiote Corp. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-12T00:15:21Z
biote Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-11T23:36:23Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $54,858,000 | $58,130,000 | $57,877,000 | $54,575,000 |
| Cost Of Revenue | $54,858,000 | $58,130,000 | $57,877,000 | $54,575,000 |
| Total Revenue | $192,219,000 | $197,191,000 | $185,360,000 | $164,957,000 |
| Operating Revenue | $192,219,000 | $197,191,000 | $185,360,000 | $164,957,000 |
| Expenses | ||||
| Interest Expense | $10,961,000 | $11,001,000 | $6,363,000 | $4,047,000 |
| Total Expenses | $156,668,000 | $165,580,000 | $156,703,000 | $225,679,000 |
| Other Income Expense | $12,994,000 | $-19,594,000 | $-22,417,000 | $66,481,000 |
| Other Non Operating Income Expenses | $-29,000 | $11,000 | $-16,000 | $29,000 |
| Net Non Operating Interest Income Expense | $-10,961,000 | $-11,001,000 | $-6,363,000 | $-4,047,000 |
| Interest Expense Non Operating | $10,961,000 | $11,001,000 | $6,363,000 | $4,047,000 |
| Operating Expense | $101,810,000 | $107,450,000 | $98,826,000 | $171,104,000 |
| Other Operating Expenses | - | - | - | $974,000 |
| Selling And Marketing Expense | - | - | - | $4,628,000 |
| General And Administrative Expense | - | - | - | $165,502,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $27,045,000 | $3,157,000 | $3,316,000 | $-969,000 |
| Net Interest Income | $-10,961,000 | $-11,001,000 | $-6,363,000 | $-4,047,000 |
| Normalized Income | $16,092,657 | $18,644,950 | $21,012,790 | $-52,360,617 |
| Net Income From Continuing And Discontinued Operation | $27,045,000 | $3,157,000 | $3,316,000 | $-969,000 |
| Total Operating Income As Reported | $35,551,000 | $31,611,000 | $28,657,000 | $-60,722,000 |
| Net Income Common Stockholders | $27,045,000 | $3,157,000 | $3,316,000 | $-969,000 |
| Net Income | $27,045,000 | $3,157,000 | $3,316,000 | $-969,000 |
| Net Income Including Noncontrolling Interests | $31,597,000 | $46,000 | $-2,805,000 | $1,324,000 |
| Net Income Continuous Operations | $31,597,000 | $46,000 | $-2,805,000 | $1,324,000 |
| Pretax Income | $37,584,000 | $1,016,000 | $-123,000 | $1,712,000 |
| Special Income Charges | $13,023,000 | $-19,605,000 | $-8,990,000 | $61,325,000 |
| Operating Income | $35,551,000 | $31,611,000 | $28,657,000 | $-60,722,000 |
| Gross Profit | $137,361,000 | $139,061,000 | $127,483,000 | $110,382,000 |
| Average Dilution Earnings | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $0.74 | $0.09 | $0.13 | $-0.12 |
| Basic EPS | $0.86 | $0.09 | $0.13 | $-0.12 |
| Other | ||||
| Tax Effect Of Unusual Items | $2,070,657 | $-4,117,050 | $-4,704,210 | $15,060,383 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $39,192,000 | $35,196,000 | $31,635,000 | $-58,494,000 |
| Total Unusual Items | $13,023,000 | $-19,605,000 | $-22,401,000 | $66,452,000 |
| Total Unusual Items Excluding Goodwill | $13,023,000 | $-19,605,000 | $-22,401,000 | $66,452,000 |
| Reconciled Depreciation | $3,670,000 | $3,574,000 | $2,994,000 | $2,199,000 |
| EBITDA (Bullshit earnings) | $52,215,000 | $15,591,000 | $9,234,000 | $7,958,000 |
| EBIT | $48,545,000 | $12,017,000 | $6,240,000 | $5,759,000 |
| Diluted Average Shares | $36,666,766 | $34,270,809 | $25,709,343 | $8,059,371 |
| Basic Average Shares | $31,283,245 | $34,270,809 | $25,709,343 | $8,059,371 |
| Diluted NI Availto Com Stockholders | $27,045,000 | $3,157,000 | $3,316,000 | $-969,000 |
| Minority Interests | $-4,552,000 | $3,111,000 | $6,121,000 | $-2,293,000 |
| Tax Provision | $5,987,000 | $970,000 | $2,682,000 | $388,000 |
| Restructuring And Mergern Acquisition | $-13,023,000 | $19,605,000 | $8,990,000 | $-61,770,000 |
| Selling General And Administration | $101,810,000 | $107,450,000 | $98,826,000 | $171,104,000 |
| Gain On Sale Of Security | - | - | $-13,411,000 | $5,127,000 |
| Other Special Charges | - | - | - | $445,000 |
| Other Gand A | - | - | - | $165,502,000 |
| Otherunder Preferred Stock Dividend | - | - | - | - |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-73,163,000 | $-121,138,000 | $-34,370,000 | $-49,532,000 |
| Total Assets | $107,613,000 | $122,370,000 | $155,295,000 | $111,645,000 |
| Total Non Current Assets | $52,943,000 | $54,243,000 | $32,952,000 | $10,467,000 |
| Other Non Current Assets | $72,000 | $72,000 | - | - |
| Non Current Deferred Assets | $24,793,000 | $28,742,000 | $24,884,000 | $1,838,000 |
| Non Current Deferred Taxes Assets | $24,793,000 | $28,742,000 | $24,884,000 | $1,838,000 |
| Goodwill And Other Intangible Assets | $14,624,000 | $15,210,000 | $4,973,000 | $5,073,000 |
| Other Intangible Assets | $8,791,000 | $9,377,000 | $4,973,000 | $5,073,000 |
| Current Assets | $54,670,000 | $68,127,000 | $122,343,000 | $101,178,000 |
| Other Current Assets | $10,000 | $111,000 | $308,000 | - |
| Prepaid Assets | $3,796,000 | $6,127,000 | $7,552,000 | $3,816,000 |
| Inventory | $19,064,000 | $14,845,000 | $17,307,000 | $11,183,000 |
| Receivables | $7,677,000 | $7,702,000 | $8,174,000 | $6,948,000 |
| Taxes Receivable | $809,000 | $71,000 | $1,365,000 | $0 |
| Accounts Receivable | $6,868,000 | $7,631,000 | $6,809,000 | $6,948,000 |
| Allowance For Doubtful Accounts Receivable | $-3,090,000 | $-1,936,000 | $-879,000 | $-974,000 |
| Gross Accounts Receivable | $9,958,000 | $9,567,000 | $7,688,000 | $7,922,000 |
| Cash Cash Equivalents And Short Term Investments | $24,123,000 | $39,342,000 | $89,002,000 | $79,231,000 |
| Cash And Cash Equivalents | $24,123,000 | $39,342,000 | $89,002,000 | $79,231,000 |
| Cash Financial | - | - | - | $79,231,000 |
| Debt | ||||
| Net Debt | $82,909,000 | $68,107,000 | $23,878,000 | $39,105,000 |
| Total Debt | $109,922,000 | $110,862,000 | $114,871,000 | $120,428,000 |
| Long Term Debt And Capital Lease Obligation | $103,080,000 | $104,089,000 | $108,310,000 | $114,013,000 |
| Long Term Debt | $100,782,000 | $101,199,000 | $106,630,000 | $112,086,000 |
| Current Debt And Capital Lease Obligation | $6,842,000 | $6,773,000 | $6,561,000 | $6,415,000 |
| Current Debt | $6,250,000 | $6,250,000 | $6,250,000 | $6,250,000 |
| Other Current Borrowings | $6,250,000 | $6,250,000 | $6,250,000 | $6,250,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $158,010,000 | $224,570,000 | $191,841,000 | $169,919,000 |
| Total Non Current Liabilities Net Minority Interest | $113,019,000 | $173,056,000 | $169,626,000 | $151,153,000 |
| Other Non Current Liabilities | $8,842,000 | $67,414,000 | $59,994,000 | $32,110,000 |
| Non Current Deferred Liabilities | $1,097,000 | $1,553,000 | $1,322,000 | $926,000 |
| Current Liabilities | $44,991,000 | $51,514,000 | $22,215,000 | $18,766,000 |
| Other Current Liabilities | $18,500,000 | $24,674,000 | - | - |
| Current Deferred Liabilities | $3,017,000 | $2,961,000 | $3,002,000 | $1,965,000 |
| Payables And Accrued Expenses | $10,821,000 | $11,461,000 | $6,584,000 | $6,165,000 |
| Payables | $6,826,000 | $5,813,000 | $4,172,000 | $5,162,000 |
| Accounts Payable | $6,826,000 | $5,813,000 | $4,155,000 | $4,112,000 |
| Total Tax Payable | - | $0 | $17,000 | $1,050,000 |
| Income Tax Payable | - | $0 | $17,000 | $1,050,000 |
| Derivative Product Liabilities | - | - | $0 | $4,104,000 |
| Current Notes Payable | - | - | - | $6,250,000 |
| Interest Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $-58,539,000 | $-105,928,000 | $-29,397,000 | $-44,459,000 |
| Total Equity Gross Minority Interest | $-50,397,000 | $-102,200,000 | $-36,546,000 | $-58,274,000 |
| Stockholders Equity | $-58,539,000 | $-105,928,000 | $-29,397,000 | $-44,459,000 |
| Gains Losses Not Affecting Retained Earnings | $-29,000 | $-35,000 | $-12,000 | $-5,000 |
| Other Equity Adjustments | $-29,000 | $-35,000 | $-12,000 | $-5,000 |
| Retained Earnings | $-49,549,000 | $-100,297,000 | $-29,391,000 | $-44,460,000 |
| Other | ||||
| Treasury Shares Number | $1,587,500 | $1,587,500 | $1,587,500 | $1,587,500 |
| Ordinary Shares Number | $30,713,367 | $31,485,777 | $34,254,883 | $9,655,387 |
| Share Issued | $32,300,867 | $33,073,277 | $35,842,383 | $11,242,887 |
| Tangible Book Value | $-73,163,000 | $-121,138,000 | $-34,370,000 | $-49,532,000 |
| Invested Capital | $48,493,000 | $1,521,000 | $83,483,000 | $73,877,000 |
| Working Capital | $9,679,000 | $16,613,000 | $100,128,000 | $82,412,000 |
| Capital Lease Obligations | $2,890,000 | $3,413,000 | $1,991,000 | $2,092,000 |
| Total Capitalization | $42,243,000 | $-4,729,000 | $77,233,000 | $67,627,000 |
| Minority Interest | $8,142,000 | $3,728,000 | $-7,149,000 | $-13,815,000 |
| Treasury Stock | $8,965,000 | $5,600,000 | $0 | - |
| Additional Paid In Capital | $0 | $0 | $0 | $0 |
| Capital Stock | $4,000 | $4,000 | $6,000 | $6,000 |
| Common Stock | $4,000 | $4,000 | $6,000 | $6,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $1,097,000 | $1,553,000 | $1,322,000 | $926,000 |
| Long Term Capital Lease Obligation | $2,298,000 | $2,890,000 | $1,680,000 | $1,927,000 |
| Current Deferred Revenue | $3,017,000 | $2,961,000 | $3,002,000 | $1,965,000 |
| Current Capital Lease Obligation | $592,000 | $523,000 | $311,000 | $165,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,811,000 | $5,645,000 | $6,068,000 | $4,221,000 |
| Current Accrued Expenses | $3,995,000 | $5,648,000 | $2,412,000 | $1,003,000 |
| Goodwill | $5,833,000 | $5,833,000 | $0 | - |
| Net PPE | $13,454,000 | $10,219,000 | $3,095,000 | $3,556,000 |
| Accumulated Depreciation | $-7,640,000 | $-6,405,000 | $-5,614,000 | $-4,810,000 |
| Gross PPE | $21,094,000 | $16,624,000 | $8,709,000 | $8,366,000 |
| Leases | $8,311,000 | $3,251,000 | $1,506,000 | $1,028,000 |
| Construction In Progress | $2,206,000 | $4,226,000 | $0 | $0 |
| Other Properties | $1,685,000 | $252,000 | - | $2,052,000 |
| Machinery Furniture Equipment | $6,191,000 | $5,649,000 | $5,326,000 | $5,286,000 |
| Buildings And Improvements | $2,701,000 | $3,246,000 | $1,877,000 | $2,052,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-3,153,000 | $-1,690,000 | $-1,272,000 | - |
| Finished Goods | $20,137,000 | $15,189,000 | $18,579,000 | $11,183,000 |
| Work In Process | $1,524,000 | $295,000 | $0 | - |
| Raw Materials | $556,000 | $1,051,000 | $0 | - |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $28,330,000 | $38,287,000 | $24,170,000 | $-10,995,000 |
| Operating Activities | ||||
| Operating Cash Flow | $35,194,000 | $45,243,000 | $26,883,000 | $-9,157,000 |
| Cash Flow From Continuing Operating Activities | $35,194,000 | $45,243,000 | $26,883,000 | $-9,157,000 |
| Operating Gains Losses | - | - | $13,411,000 | $-4,682,000 |
| Investing Activities | ||||
| Capital Expenditure | $-6,864,000 | $-6,956,000 | $-2,713,000 | $-1,838,000 |
| Investing Cash Flow | $-6,864,000 | $-18,798,000 | $-2,713,000 | $-1,838,000 |
| Cash Flow From Continuing Investing Activities | $-6,864,000 | $-18,798,000 | $-2,713,000 | $-1,838,000 |
| Capital Expenditure Reported | $-1,849,000 | $-526,000 | $-2,354,000 | $-1,505,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-3,365,000 | $-5,599,000 | $0 | $-424,000 |
| Issuance Of Capital Stock | $142,000 | $282,000 | $144,000 | $442,000 |
| Financing Cash Flow | $-43,555,000 | $-76,083,000 | $-14,380,000 | $63,460,000 |
| Cash Flow From Continuing Financing Activities | $-43,555,000 | $-76,083,000 | $-14,380,000 | $63,460,000 |
| Net Other Financing Charges | $-37,581,000 | $-62,162,000 | - | $-797,000 |
| Cash Dividends Paid | $-1,727,000 | $-4,744,000 | $-8,694,000 | $-12,886,000 |
| Net Common Stock Issuance | $-3,223,000 | $-5,317,000 | $144,000 | $18,000 |
| Common Stock Issuance | $142,000 | $282,000 | $144,000 | $442,000 |
| Common Stock Dividend Paid | - | - | - | $-12,886,000 |
| Other | ||||
| Repayment Of Debt | $-6,250,000 | $-6,250,000 | $-6,250,000 | $-40,625,000 |
| Issuance Of Debt | $5,000,000 | $0 | $0 | $125,000,000 |
| Interest Paid Supplemental Data | $7,877,000 | $9,535,000 | $9,476,000 | $4,426,000 |
| Income Tax Paid Supplemental Data | $2,752,000 | $2,593,000 | $4,426,000 | $282,000 |
| End Cash Position | $24,123,000 | $39,342,000 | $89,002,000 | $79,231,000 |
| Beginning Cash Position | $39,342,000 | $89,002,000 | $79,231,000 | $26,766,000 |
| Effect Of Exchange Rate Changes | $6,000 | $-22,000 | $-19,000 | $0 |
| Changes In Cash | $-15,225,000 | $-49,638,000 | $9,790,000 | $52,465,000 |
| Proceeds From Stock Option Exercised | $226,000 | $2,390,000 | $420,000 | $-7,250,000 |
| Common Stock Payments | $-3,365,000 | $-5,599,000 | $0 | $-424,000 |
| Net Issuance Payments Of Debt | $-1,250,000 | $-6,250,000 | $-6,250,000 | $84,375,000 |
| Net Long Term Debt Issuance | $-1,250,000 | $-6,250,000 | $-6,250,000 | $84,375,000 |
| Long Term Debt Payments | $-6,250,000 | $-6,250,000 | $-6,250,000 | $-40,625,000 |
| Long Term Debt Issuance | $5,000,000 | $0 | $0 | $125,000,000 |
| Net Business Purchase And Sale | $0 | $-11,842,000 | $0 | - |
| Purchase Of Business | $0 | $-11,842,000 | $0 | - |
| Net PPE Purchase And Sale | $-5,015,000 | $-6,430,000 | $-359,000 | $-333,000 |
| Purchase Of PPE | $-5,015,000 | $-6,430,000 | $-359,000 | $-333,000 |
| Change In Working Capital | $-8,159,000 | $9,934,000 | $-8,927,000 | $-35,814,000 |
| Change In Other Working Capital | $-400,000 | $190,000 | $1,433,000 | $384,000 |
| Change In Other Current Liabilities | $-523,000 | $-762,000 | $-397,000 | $-219,000 |
| Change In Other Current Assets | $1,694,000 | $2,882,000 | $-5,418,000 | $-2,284,000 |
| Change In Payables And Accrued Expense | $-1,730,000 | $6,177,000 | $2,058,000 | $-30,425,000 |
| Change In Accrued Expense | $-2,743,000 | $4,632,000 | $2,223,000 | $-30,841,000 |
| Change In Payable | $1,013,000 | $1,545,000 | $-165,000 | $416,000 |
| Change In Account Payable | $1,013,000 | $1,545,000 | $-165,000 | $416,000 |
| Change In Inventory | $-6,242,000 | $3,714,000 | $-6,098,000 | $-1,708,000 |
| Change In Receivables | $-958,000 | $-2,267,000 | $-505,000 | $-1,562,000 |
| Changes In Account Receivables | $-958,000 | $-2,267,000 | $-505,000 | $-1,562,000 |
| Other Non Cash Items | $-8,554,000 | $23,859,000 | $11,482,000 | $-53,606,000 |
| Stock Based Compensation | $8,921,000 | $8,735,000 | $9,057,000 | $82,180,000 |
| Provisionand Write Offof Assets | $2,023,000 | $503,000 | $-26,000 | $140,000 |
| Asset Impairment Charge | $1,721,000 | $1,490,000 | $976,000 | $-155,000 |
| Deferred Tax | $3,975,000 | $-2,898,000 | $721,000 | $-743,000 |
| Deferred Income Tax | $3,975,000 | $-2,898,000 | $721,000 | $-743,000 |
| Depreciation Amortization Depletion | $3,670,000 | $3,574,000 | $2,994,000 | $2,199,000 |
| Depreciation And Amortization | $3,670,000 | $3,574,000 | $2,994,000 | $2,199,000 |
| Net Income From Continuing Operations | $31,597,000 | $46,000 | $-2,805,000 | $1,324,000 |
| Gain Loss On Investment Securities | - | - | $13,411,000 | $-5,127,000 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |
Fetched: 2026-06-15